Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT studyAndrew J. Burger, Uri Elkayam, Darlene P. Horton et al.|American Heart Journal|2002Cited by 323
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failureRoger M. Mills, Kanu Chatterjee, Chang‐seng Liang et al.|Journal of the American College of Cardiology|1999Cited by 323
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failureMarc A. Silver, Uri Elkayam, Darlene P. Horton et al.|Journal of the American College of Cardiology|2002Cited by 232
Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)Clyde W. Yancy, Marc A. Silver, Mitchell Saltzberg et al.|The American Journal of Cardiology|2004Cited by 103
Management of patients with congestive heart failure after hospitalization: results from the follow up serial infusions of nesiritide (FUSION) trialClyde W. Yancy, Marc A. Silver, Mitchell Saltzberg et al.|Journal of Cardiac Failure|2003Cited by 14